C
VTYX

Covestor’s Ventyx Biosciences VTYX Stock Holding History

Covestor’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-30
Closed – – 2804
2025
Q1 		$0 Hold
30
– – ﹤0.01% 2776
2024
Q4 		$0 Buy
30
+2
+7% +$5 ﹤0.01% 2792
2024
Q3 		$0 Buy
28
+15
+115% +$34 ﹤0.01% 2822
2024
Q2 		$0 Hold
13
– – ﹤0.01% 2811
2024
Q1 		$0 Buy
13
+9
+225% +$41 ﹤0.01% 2796
2023
Q4 		$0 Hold
4
– – ﹤0.01% 2773
2023
Q3 		$0 Sell
4
-1
-20% -$35 ﹤0.01% 2767
2023
Q2 		$0 Hold
5
– – ﹤0.01% 2706
2023
Q1 		$0 Hold
5
– – ﹤0.01% 2641
2022
Q4 		$0 Buy
+5
New +$148 ﹤0.01% 2658

Other funds holding VTYX

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Covestor's VTYX Position: Q2 2025 in Review

Covestor sold out of Ventyx Biosciences (VTYX) in Q2 2025, closing a stake of 30 shares.

Covestor first reported a position in VTYX in Q4 2022 and held it in 10 quarters. The position peaked at $0 in Q1 2025. 114 funds tracked by Wall St. Rank hold VTYX as of Q2 2025.

  • Covestor reported no remaining Ventyx Biosciences position as of Q2 2025 after selling out during the quarter.
  • Covestor sold 30 Ventyx Biosciences shares in Q2 2025.
  • Covestor first reported a position in Ventyx Biosciences in Q4 2022 and held it in 10 quarters.
  • Covestor's Ventyx Biosciences position peaked at $0 in Q1 2025.
  • 114 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q2 2025.

Based on Covestor's 13F filing for Q2 2025, filed 11 Aug 2025.